Nucleoside Tag Protein Detection via Antibody Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for tagging proteins in biological research and medical diagnostics face challenges such as protein function and localization interference, toxicity, and insufficient sensitivity and specificity, particularly with direct labeling and fluorescent molecules.

Innovation Solution

The use of nucleosides or nucleoside analogs as tags, which are attached to proteins and detected using specific binding reagents, allowing for precise localization and quantification of proteins in biological samples through methods like flow cytometry and immunohistochemistry.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If direct labelling of proteins with fluorophore dyes or fusion tags is used, then detection capability is improved, but protein function and localization are interfered with due to large tag size

Engineering Contradiction:
Improvedetection capabilityVSAvoidprotein function and localization
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention extracts the detection function from large protein tags and fluorophores, replacing them with small nucleoside analog tags (e.g., 5-iodo-2'-deoxyuridine, 5-bromo-2'-deoxyuridine) that can be incorporated into proteins during translation. These minimal tags provide detection capability while causing negligible interference with protein function and localization, directly resolving the contradiction between detection precision and protein reliability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the detection parameter from large molecular tags (fluorophores, fusion proteins) to small chemical nucleoside analogs. This parameter change in tag size and chemical nature enables detection while preserving protein behavior, as the nucleoside tags are small molecules that do not significantly alter protein structure or function compared to large fluorophore or fusion tag labels.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If fluorescent molecules such as fluorescein are used for tagging, then detection is enabled, but background fluorescence increases reducing specificity

Engineering Contradiction:
Improvedetection sensitivityVSAvoidbackground fluorescence
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The invention introduces an intermediary detection system where nucleoside analog tags (e.g., 5-iodo-2'-deoxyuridine, 5-bromo-2'-deoxyuridine) are incorporated into proteins, and then specific antibodies or binding reagents are used to detect these tags. This intermediary approach eliminates background fluorescence because the nucleoside tags themselves are non-fluorescent, and only the specific binding reagents produce detectable signals, thereby improving detection specificity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If traditional tagging methods are used, then protein detection is achieved, but toxicity is induced or sensitivity and specificity are insufficient

Engineering Contradiction:
Improvesensitivity and specificityVSAvoidtoxicity
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The invention uses transient, non-persistent nucleoside analog tags (e.g., 5-iodo-2'-deoxyuridine, 5-bromo-2'-deoxyuridine) that are incorporated into proteins during translation and can be detected without long-term persistence. These tags are metabolically stable enough for detection but do not accumulate to toxic levels, providing a disposable tagging approach that maintains sensitivity and specificity while minimizing toxicity compared to traditional fluorescent proteins or chemical labels.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables simultaneous tracking of multiple proteins with high sensitivity and specificity, without interfering with protein behavior, and allows for confirmation of results through chemical modification of the tags, providing a robust method for protein detection and localization.

Implementation Method 1

contacting the biological sample with a binding reagent that binds specifically to the tag

Methodology Applied
Scientific EffectSpecific binding: Adsorption

Implementation Method 2

The binding reagent may contain or be attached to a fluorescent group, which makes the binding reagent fluorescent. In this case, the location of the tagged protein in the sample is determined by obtaining an image of fluorescence emitted from the florescent group on the binding reagent.

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20230375556A1Protein detection and tracking using nucleoside tags
Publication Date: 2023.11.23 MGI TECH CO LTD
  • US20230375556A1 patent drawing
  • US20230375556A1 patent drawing
  • US20230375556A1 patent drawing

AI summary

Provided are methods and reagents for detecting polypeptides using nucleosides or nucleoside analogs as tags. In particular, a tagged polypeptide is contacted with a binding reagent (such as an antibody) that binds specifically to the nucleoside tag portion of the tagged polypeptide. The binding of the binding reagent to the nucleoside tag portion of the tagged polypeptide is then detected, thereby quantifying or localizing the tagged polypeptide. Provided is a variety of uses of this technology. For example, the tag specific antibodies can be presented in an array that is suitable for quantifying or characterizing a number of tagged proteins in a number of liquid samples. The technology can also be used to track a large number of tagged proteins in vivo, for example, by multiplex immunohistochemistry.